virus News
Most Popular virus Story
Investors disappointed in Vertex despite strong data
Vertex shares sank on Friday after the company reported that its closely-watched hepatitis C drug telaprevir eradicated the virus in more than 60 percent of patients. Standard therapies on the market Read more...
Latest Headlines
- August 11, 2011
- February 21, 2008
- February 12, 2008
- November 14, 2007
- November 5, 2007
- August 20, 2007
- July 8, 2007
- December 12, 2006
- October 18, 2006
- August 2, 2006
- June 22, 2006
- May 21, 2006
- May 2, 2006
- April 18, 2006
- March 22, 2006
- March 16, 2006
- February 12, 2006
- February 9, 2006
- February 7, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
